Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-26 Sale |
2021-07-27 5:25 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
8,949 | $39.78 | $355,977 | 1,195,830 (Indirect) |
View |
| 2021-07-26 Sale |
2021-07-27 5:23 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
8,949 | $39.78 | $355,977 | 1,195,830 (Indirect) |
View |
| 2021-07-12 Sale |
2021-07-14 5:18 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
23,149 | $42.01 | $972,456 | 1,309,409 (Indirect Direct) |
View |
| 2021-07-12 Sale |
2021-07-14 5:17 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
17,934 | $42.01 | $753,369 | 1,204,779 (Indirect) |
View |
| 2021-07-06 Sale |
2021-07-08 7:37 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
73,117 | $42.19 | $3,085,027 | 1,222,713 (Indirect) |
View |
| 2021-07-06 Sale |
2021-07-08 7:36 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
88,489 | $42.19 | $3,733,762 | 1,327,490 (Indirect Direct) |
View |
| 2021-06-25 Sale |
2021-06-29 8:31 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
1,314,912 | $42.11 | $55,370,134 | 6,227,558 (Indirect Direct) |
View |
| 2021-06-10 Sale |
2021-06-14 6:42 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
70,000 | $46.49 | $3,254,369 | 520,960 (Indirect Direct) |
View |
| 2021-06-04 Sale |
2021-06-08 8:15 pm |
Royalty Pharma plc | RPRX | Urist Marshall EVP & Co-Head of R&I |
33,134 | $46.08 | $1,526,721 | 19,020 (Indirect Direct) |
View |
| 2021-06-07 Sale |
2021-06-08 8:13 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
273,650 | $45.26 | $12,385,399 | 8,476,380 (Indirect Direct) |
View |
| 2021-06-04 Sale |
2021-06-08 8:12 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
252,500 | $46.01 | $11,616,797 | 530,960 (Indirect Direct) |
View |
| 2021-06-04 Sale |
2021-06-08 8:12 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
200,000 | $45.55 | $9,110,689 | 1,295,830 (Indirect) |
View |
| 2021-06-02 Sale |
2021-06-04 6:52 pm |
Royalty Pharma plc | RPRX | Urist Marshall EVP & Co-Head Research & Inv. |
14,566 | $41.52 | $604,850 | 52,154 (Indirect Direct) |
View |
| 2021-06-02 Sale |
2021-06-04 6:50 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
50,000 | $42.13 | $2,106,560 | 1,495,830 (Indirect) |
View |
| 2021-06-02 Sale |
2021-06-04 6:48 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
62,500 | $42.12 | $2,632,513 | 1,626,960 (Indirect Direct) |
View |
| 2021-05-20 Sale |
2021-05-24 8:10 pm |
Royalty Pharma plc | RPRX | Urist Marshall EVP & Co-Head Research & Inv. |
2,000 | $41.08 | $82,159 | 66,720 (Indirect Direct) |
View |
| 2021-04-14 Sale |
2021-04-16 5:57 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
69,822 | $42.13 | $2,941,920 | 476,960 (Indirect Direct) |
View |
| 2021-04-14 Sale |
2021-04-16 5:56 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
55,714 | $42.1 | $2,345,593 | 225,030 (Indirect) |
View |
| 2021-04-12 Sale |
2021-04-14 07:52 am |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
449 | $42.32 | $19,002 | 532,858 (Indirect Direct) |
View |
| 2021-04-12 Sale |
2021-04-14 07:51 am |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
359 | $42.32 | $15,193 | 280,744 (Indirect) |
View |
| 2021-03-22 Sale |
2021-03-24 5:25 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
43,927 | $46.32 | $2,034,519 | 281,103 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-30 Option Award |
2021-06-30 5:50 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
871 | $43.04 | 41,686 (Direct) |
View |
| 2021-06-30 Option Award |
2021-06-30 5:15 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
871 | $43.04 | 21,780 (Direct) |
View |
| 2021-06-30 Option Award |
2021-06-30 5:11 pm |
N/A N/A |
Royalty Pharma plc | RPRX | FORD WILLIAM E Director |
871 | $43.04 | 2,046,365 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 8:43 pm |
N/A N/A |
Royalty Pharma plc | RPRX | LOVE TED W Director |
5,726 | $0 | 22,866 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 8:34 pm |
N/A N/A |
Royalty Pharma plc | RPRX | DESOUZA ERROL B Director |
5,726 | $0 | 50,370 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 8:30 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
5,726 | $0 | 20,909 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 8:29 pm |
N/A N/A |
Royalty Pharma plc | RPRX | FORD WILLIAM E Director |
5,726 | $0 | 2,045,495 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 8:28 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
5,726 | $0 | 40,815 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 8:26 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Norden Gregory Director |
5,726 | $0 | 50,370 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 8:22 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Engelbert Catherine M. Director |
5,726 | $0 | 19,136 (Direct) |
View |
| 2021-05-07 Conversion |
2021-05-11 9:08 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Urist Marshall EVP & Co-Head Research & Inv. |
54,670 | $0 | 211,314 (Direct) |
View |
| 2021-05-07 Conversion |
2021-05-11 9:06 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Reddoch James F. EVP, Research & Investments |
1,452,880 | $0 | 2,032,228 (Indirect) |
View |
| 2021-05-07 Conversion |
2021-05-11 9:05 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
1,100,000 | $0 | 1,346,858 (Indirect) |
View |
| 2021-05-07 Conversion |
2021-05-11 9:05 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
2,063,446 | $0 | 1,020,838 (Indirect) |
View |
| 2021-05-07 Conversion |
2021-05-11 9:03 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board |
2,557,500 | $0 | 7,406,417 (Indirect) |
View |
| 2021-05-07 Conversion |
2021-05-11 9:00 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
3,338,445 | $0 | 9,291,781 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-02 5:35 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
816 | $45.9 | 15,183 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-02 5:30 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
816 | $45.9 | 35,229 (Direct) |
View |